pulmonary-disease

Documents about pulmonary-disease

• Effect of Home-base Exercise With Conical-PEP Device on Physical Performance and Quality of Life in COPD#833505ClinicalTrials.gov
• Altered Carnitine Homeostasis in Children With Increased Pulmonary Blood Flow Due to Ventricular Septal Defects#614720eScholarship
• Off-label use of Lifetech KONAR-MF™ ventricular septal defect occluder for large patent ductus arteriosus closure in <6 ​kg infants#257547HAL (France)
• ATP/AMP Challenge in Healthy Non-smokers, Smokers, Patients With Asthma, and Patients With Chronic Obstructive Pulmonary Disease (COPD)#835941ClinicalTrials.gov
• Information-Motivation-Behavioral Skills Model-based Intervention to Domiciliary Non-invasive Ventilation of Patients#844472ClinicalTrials.gov
• Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchitis#847930ClinicalTrials.gov
• Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease#853387ClinicalTrials.gov
• An Integrative Genomic Approach to Solve tHe Puzzle of sevERe earLy-Onset COPD#861502ClinicalTrials.gov
• A Study of the Effect of a Nurse Navigator Program on High Risk Patients#885497ClinicalTrials.gov
• ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension#806514ClinicalTrials.gov
• Inhaled nitric oxide in fibrotic and advanced interstitial lung disease: A systematic review and meta-analysis of randomized controlled trials#302061PLOS
• The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study#807802ClinicalTrials.gov
• Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema#833463ClinicalTrials.gov
• VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management#839687ClinicalTrials.gov
• {'@classid': 'main title', '@classname': 'main title', '@schemeid': 'dnet:dataCite_title', '@schemename': 'dnet:dataCite_title', '@inferred': False, '@provenanceaction': 'sysimport:crosswalk:repository', '@trust': '0.9', '$': 'A Case of Eosinophilic Granulomatosis with Polyangiitis Complicated with A IgG4 Related Disease Like Symptoms'}#491148OpenAIRE
• Epidemiology, prehospital care and outcomes of patients arriving by ambulance with dyspnoea: An observational study#190670UNSWorks Repository
• Multicentre prospective cohort study to develop and validate a machine learning-based model for predicting 6-month all-cause mortality in elderly patients with advanced chronic obstructive pulmonary disease in China: study protocol.#239688NCBI PubMed Central
• A Study to Assess the Effects of GSK573719/VI Combination and GSK573719 Monotherapy in Subjects With Moderate Hepatic Impairment and Matched Healthy Volunteers#811881ClinicalTrials.gov
• Bioelectrical Impedance in Monitoring Hyperhydration and Polyneuromyopathy in Critically Ill Patients#847516ClinicalTrials.gov
• Rural Home Hospital: Proof of Concept#850499ClinicalTrials.gov
• Does PaCO2 correction have an impact on survival of patients with chronic respiratory failure and long-term non-invasive ventilation?#68275HAL (France)
• Assessment of Long-term Sequelae of Coronavirus Disease 2019 (COVID-19) Pneumonia With Chest CT and Pulmonary Function Tests#160195ClinicalTrials.gov
• Comparative effectiveness of different inhaler technique education modalities on clinical outcomes in patients with asthma and chronic obstructive pulmonary disease: a protocol for a systematic review and network meta-analysis of randomised controlled trials.#309019NCBI PubMed Central
• Safety and Effectiveness of a Virtual Pediatric Cardiac Rehabilitation Program or Telerehabilitation in Children With Heart Disease#843336ClinicalTrials.gov
• Effect of Pursed-Lip Breathing With Different I:E Ratios on Respiratory Outcomes in COPD Patients#876517ClinicalTrials.gov
• Insights into interstitial lung disease pathogenesis.#628426Apollo
• A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response.#633746ClinicalTrials.gov
• A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose in Healthy Volunteers, Repeat Doses in Asthmatic Patients and of Single Dose in COPD Patients of CHF6366#878793ClinicalTrials.gov
• Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.#868767ClinicalTrials.gov
• Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality#881377ClinicalTrials.gov
• Strategy for Early Treatment of Exacerbations in COPD: Standing Prescriptions of Advair With a Written Action Plan in the Event of an Exacerbation#848858ClinicalTrials.gov
• Comparison of High-flow Oxygen vs. BiPAP in Type II (Hypercapnic) Respiratory Failure#886303ClinicalTrials.gov
• A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence#343683ClinicalTrials.gov
• Magnet Resonance Imaging to Evaluate of Dynamic T2 Preparation Puls by Patients With Shunt or Chronic Obstructive Pulmonary Disease#836799ClinicalTrials.gov
• Data Sheet 2_Evaluating Cordyceps militaris capsules on post-bronchodilator FEV1 decline in patients with COPD: a study protocol for double-blind, randomized, placebo-controlled trial.docx#222490Figshare
• Data Sheet 5_Evaluating Cordyceps militaris capsules on post-bronchodilator FEV1 decline in patients with COPD: a study protocol for double-blind, randomized, placebo-controlled trial.docx#222491Figshare
• Data Sheet 4_Evaluating Cordyceps militaris capsules on post-bronchodilator FEV1 decline in patients with COPD: a study protocol for double-blind, randomized, placebo-controlled trial.pdf#222492Figshare
• Data Sheet 3_Evaluating Cordyceps militaris capsules on post-bronchodilator FEV1 decline in patients with COPD: a study protocol for double-blind, randomized, placebo-controlled trial.pdf#222493Figshare
• Data Sheet 1_Evaluating Cordyceps militaris capsules on post-bronchodilator FEV1 decline in patients with COPD: a study protocol for double-blind, randomized, placebo-controlled trial.docx#222494Figshare
• A Retrospective rEal-life daTa Study to Assess the exaceRbations and Lung functIon in Chronic Obstructive Pulmonary Disease ( COPD ) patiEnts receiVing Fluticasone/Salmeterol Comparing to Those Εscalating in Open-triple Fluticasone/Salmeterol, Long Acting Muscarinic Antagonist (LAMA) Combination#811251ClinicalTrials.gov
• The Prescriptive Validity of a Novel Fall Risk Clinical Prediction Rule for People With COPD#810844ClinicalTrials.gov
• Exploring Acceptance and Outcomes of an Online-based Self-management Support System in Chronic Illness#884637ClinicalTrials.gov
• Additional file 1 of Assessment of pulmonary function test in type 2 diabetes mellitus and its relation to glycaemic control and duration of disease#402229Figshare
• Multi-level Integration for Patients With Complex Needs Facilitated by ICTs. A Shared Approach, Mutual Learning and Evaluation Are Expected to Create Synergies Among the Partners and to Bring Forward Integration of Care in Europe#803768ClinicalTrials.gov
• A Retrospective Study to Evaluate the Predictability of Abnormal Arterial Blood Gas Measurements Through Novel Observations of Continuous Trends in Electronically Measured Respiratory Rate in a Mixed Cohort of Respiratory Compromised Patients#842462ClinicalTrials.gov
• Study to Assess the Effect of the Aerobika Device in Addition to Standard of Care Treatment in Sputum Producing COPD Patients Using FRI#867680ClinicalTrials.gov
• A Phase I Pharmacokinetic Study of Fluticasone Furoate /Umeclidinium Bromide/Vilanterol (100/62.5/25 Microgram [mcg]) After Single and Repeat Dose Administration From a Dry Powder Inhaler in Healthy Chinese Subjects#805367ClinicalTrials.gov
• Impaired Sleep Quality in COPD Is Associated With Exacerbations The CanCOLD Cohort Study#620137eScholarship
• Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies#802013ClinicalTrials.gov
• Potential of Interface Care Models to Deliver More Appropriate Care to Patients With Acute Medical Illness#852218ClinicalTrials.gov